Search results for "Radiation-Sensitizing Agents"

showing 10 items of 22 documents

Cetuximab in squamous cell head and neck carcinomas.

2007

The epidermal growth factor receptor (EGFR) antagonist, cetuximab, has recently been shown to enhance the effects of radiotherapy, and reports to date indicate that this effect occurs without any change in the pattern and severity of toxicity usually associated with head and neck radiation and/or chemotherapy (CT) administration. Moreover, several studies have reported that the expression of EGFR is strongly linked to poor outcome in patients undergoing therapy. Therefore, the presence of the EGFR in almost all cases of head and neck carcinoma offers a new therapeutic opportunity to most patients. In this paper, we report a review of the major studies dealing with the use of cetuximab in ad…

Oncologymedicine.medical_specialtyRadiation-Sensitizing Agentsmedicine.medical_treatmentCetuximabAntineoplastic AgentsAntibodies Monoclonal HumanizedClinical Trials Phase II as TopicInternal medicinemedicineCarcinomaAnimalsHumansEpidermal growth factor receptorSquamous epithelial cellCetuximabbiologyClinical Trials Phase I as Topicbusiness.industryHead and neck cancerAntibodies MonoclonalHematologymedicine.diseaseHead and neck squamous-cell carcinomaChemotherapy regimenRadiation therapyneck carcinomasmedicine.anatomical_structureOncologyHead and Neck Neoplasmsbiology.proteinCarcinoma Squamous CellNeoplasm Recurrence Localbusinessmedicine.drugAnnals of oncology : official journal of the European Society for Medical Oncology
researchProduct

Recombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude mice

2001

Purpose: The effect of recombinant human erythropoietin (Epo) on the radiosensitivity of human tumour xenografts growing in anaemic nude mice was studied. Methods and materials: Anaemia was induced by total body irradiation (TBI) of mice prior to tumour transplantation. The development of anaemia was prevented by Epo (1000 U/kg s.c.) given 3 times weekly starting 2 weeks prior to TBI (5 Gy). Epo treatment did not influence the growth rate of the tumours, which were transplanted into the subcutis of the hind leg of mice. Thirteen days after TBI (tumour volume of approx. 40 mm3), a single-dose irradiation (12 Gy) of the tumour was performed resulting in a growth delay with subsequent regrowth…

Radiation-Sensitizing AgentsCancer ResearchPathologymedicine.medical_specialtyRatónAnemiaMice NudeBiologyMicehemic and lymphatic diseasesInternal medicinemedicineAnimalsHumansRadiosensitivityddc:610ErythropoietinHematologyAnemiaNeoplasms ExperimentalGeneral MedicineTotal body irradiationHypoxia (medical)medicine.diseaseCombined Modality TherapyXenograft Model Antitumor AssaysCell HypoxiaRecombinant ProteinsTransplantationOncologyErythropoietinCancer researchmedicine.symptomCell Divisionmedicine.drug
researchProduct

The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: A proof-of-concept

2013

Abstract Background and purpose One of the new challenges to improve radiotherapy is to increase the ionizing effect by using nanoparticles. The interest of titanate nanotubes (TiONts) associated with radiotherapy was evaluated in two human glioblastoma cell lines (SNB-19 and U87MG). Materials and methods Titanate nanotubes were synthetized by the hydrothermal treatment of titanium dioxide powder in a strongly basic NaOH solution. The cytotoxicity of TiONts was evaluated on SNB-19 and U87MG cell lines by cell proliferation assay. The internalization of TiONts was studied using Transmission Electron Microscopy (TEM). Finally, the effect of TiONts on cell radiosensitivity was evaluated using …

Radiation-Sensitizing AgentsCell SurvivalDNA repairCellApoptosisFlow cytometryCell Line TumormedicineHumansRadiology Nuclear Medicine and imagingRadiosensitivityClonogenic assayCytotoxicityTitaniumNanotubesmedicine.diagnostic_testBrain NeoplasmsChemistryCell growthCell CycleHematologyCell cyclemedicine.anatomical_structureOncologyBiophysicsGlioblastomaReactive Oxygen SpeciesDNA DamageRadiotherapy and Oncology
researchProduct

A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein surviv…

2011

Abstract Background and purpose Novel strategies to overcome an irradiation resistant phenotype may help to increase therapeutic efficacy in glioblastoma multiforme. The present study aimed to elucidate radiation sensitizing properties of artesunate, a semi synthetic derivate of artemisinin and to assess factors involved in this effect. Materials and methods LN229 and U87MG cells were treated with various concentrations of artesunate and radiation response was determined by a colony forming assay. Cell numbers, apoptosis induction, cell cycle distribution, and DNA repair following combined modality treatment were monitored by MTT-, caspase 3/7 assay, cytofluorometry, and γ-H2AX foci formati…

Radiation-Sensitizing AgentsDNA RepairCell SurvivalSurvivinArtesunateDown-RegulationCaspase 3ApoptosisInhibitor of apoptosisInhibitor of Apoptosis Proteinschemistry.chemical_compoundCell Line TumorSurvivinHumansRadiology Nuclear Medicine and imagingClonogenic assayDose-Response Relationship DrugBrain NeoplasmsCell CycleHematologyCell cycleArtemisininsXIAPNeoplasm ProteinsOncologychemistryArtesunateApoptosisCancer researchGlioblastomaRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
researchProduct

Evaluation of Epigenetic and Radiomodifying Effects during Radiotherapy Treatments in Zebrafish

2021

Radiotherapy is still a long way from personalizing cancer treatment plans, and its effectiveness depends on the radiosensitivity of tumor cells. Indeed, therapies that are efficient and successful for some patients may be relatively ineffective for others. Based on this, radiobiological research is focusing on the ability of some reagents to make cancer cells more responsive to ionizing radiation, as well as to protect the surrounding healthy tissues from possible side effects. In this scenario, zebrafish emerged as an effective model system to test for radiation modifiers that can potentially be used for radiotherapeutic purposes in humans. The adoption of this experimental organism is fu…

Radiation-Sensitizing AgentsEmbryo NonmammalianQH301-705.5medicine.medical_treatmentEmbryonic DevelopmentSettore BIO/11 - Biologia MolecolareReviewBioinformaticsCatalysisEpigenesis GeneticInorganic Chemistryembryogenesis; epigenetics; radiomodifiers; radiotherapy; zebrafish.In vivomedicineAnimalsEpigeneticsRadiosensitivityBiology (General)Physical and Theoretical ChemistryQD1-999Molecular BiologyZebrafishradiotherapySpectroscopyradiomodifiersepigeneticsbiologybusiness.industryOrganic ChemistryGeneral Medicinezebrafishbiology.organism_classificationComputer Science ApplicationsCancer treatmentRadiation therapyChemistryModels AnimalCancer cellembryogenesisbusinessExperimental OrganismInternational Journal of Molecular Sciences
researchProduct

The contribution of hydrogen peroxide to the radiosensitizing effect of gold nanoparticles

2019

Abstract Plasmid DNA in aerated aqueous solution is used as a probe to determine whose of the reactive oxygen species (ROS) generated after absorption of ultra-soft X-rays (USX) take part in biomolecule damage in the presence and in absence of Gold Nano-Particles (GNP) and specific scavengers. Citrate-coated GNPs with core sizes of 6, 10 and 25 nm are synthetized and characterized, especially in terms of plasmon band shift, ζ-potential and hydrodynamic radii (respectively 9, 21 and 30 nm). We confirm the radiosensitizing effect of GNP and show that the SSB number per plasmid increases when, for a same mass of gold element, the core size of the gold nanoparticles decreases. Hydroxyl radicals…

Radiation-Sensitizing AgentsFormatesRadicalMetal Nanoparticles02 engineering and technologyPhotochemistry01 natural sciencesCitric AcidMetalchemistry.chemical_compoundColloid and Surface ChemistryPyruvic Acid0103 physical sciences[CHIM]Chemical SciencesMoleculeDimethyl SulfoxideDNA Breaks Single-StrandedParticle SizeTromethaminePhysical and Theoretical ChemistryHydrogen peroxideComputingMilieux_MISCELLANEOUSchemistry.chemical_classificationReactive oxygen speciesQuenching (fluorescence)Aqueous solution010304 chemical physicsHydroxyl RadicalX-RaysFree Radical ScavengersHydrogen PeroxideSurfaces and InterfacesGeneral Medicine021001 nanoscience & nanotechnologySolutionschemistryColloidal goldvisual_artvisual_art.visual_art_mediumGold0210 nano-technologyPlasmidsBiotechnologyColloids and Surfaces B: Biointerfaces
researchProduct

AGuIX® from bench to bedside-Transfer of an ultrasmall theranostic gadolinium-based nanoparticle to clinical medicine.

2019

International audience; AGuIX® are sub-5 nm nanoparticles made of a polysiloxane matrix and gadolinium chelates. This nanoparticle has been recently accepted in clinical trials in association with radiotherapy. This review will summarize the principal preclinical results that have led to first in man administration. No evidence of toxicity has been observed during regulatory toxicity tests on two animal species (rodents and monkeys). Biodistributions on different animal models have shown passive uptake in tumours due to enhanced permeability and retention effect combined with renal elimination of the nanoparticles after intravenous administration. High radiosensitizing effect has been obser…

Radiation-Sensitizing AgentsGadoliniummedicine.medical_treatmentGadolinium02 engineering and technologyReview ArticlePharmacologyTheranostic NanomedicineMice0302 clinical medicineMelanomaBrain NeoplasmsMelanomaGeneral Medicine[CHIM.MATE]Chemical Sciences/Material chemistry[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences021001 nanoscience & nanotechnology3. Good health[SDV.SP] Life Sciences [q-bio]/Pharmaceutical sciencesNuclear Medicine & Medical ImagingRadiology Nuclear Medicine and imagingHead and Neck Neoplasms030220 oncology & carcinogenesisToxicity/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being[SDV.IB]Life Sciences [q-bio]/Bioengineering0210 nano-technologyClinical Scienceschemistry.chemical_element[SDV.CAN]Life Sciences [q-bio]/CancerEnhanced permeability and retention effect03 medical and health sciences/dk/atira/pure/subjectarea/asjc/2700/2741SDG 3 - Good Health and Well-being[SDV.CAN] Life Sciences [q-bio]/CancerIn vivo[CHIM.ANAL]Chemical Sciences/Analytical chemistrymedicineAnimalsHumansRadiology Nuclear Medicine and imaging[SDV.IB] Life Sciences [q-bio]/Bioengineeringbusiness.industryCancermedicine.diseaseRadiation therapyClinical trialchemistryNanoparticlesbusinessForecasting
researchProduct

Resveratrol as a Chemopreventive Agent: A Promising Molecule for Fighting Cancer

2006

International audience; Resveratrol (3,4',5 tri-hydroxystilbene) is a phytoalexin produced in hudge amount in grapevine skin in response to infection by Bothrytis cinerea. This production of resveratrol blocks the proliferation of the pathogen, thereby acting as a natural antibiotic. Numerous studies have reported interesting properties of trans-resveratrol as a preventive agent against important pathologies i.e. vascular diseases, cancers, viral infection or neurodegenerative processes. Moreover, several epidemiological studies have revealed that resveratrol is probably one of the main microcomponents of wine responsible for its health benefits such as prevention of vaso-coronary diseases …

Radiation-Sensitizing AgentsMESH : Radiation-Sensitizing AgentsAngiogenesisClinical BiochemistryTumor initiationPharmacologyResveratrolBiologyMESH : Antineoplastic Agents Phytogenicmedicine.disease_causeMESH : Anticarcinogenic AgentsMESH : Stilbeneschemistry.chemical_compoundNeoplasmsMESH : Cell CycleStilbenesDrug DiscoverymedicineAnimalsAnticarcinogenic AgentsHumansCytotoxicity[ SDV.BBM ] Life Sciences [q-bio]/Biochemistry Molecular BiologyPharmacologychemistry.chemical_classificationPhytoalexinMESH : HumansCell Cyclefood and beveragesCancerCell cyclemedicine.diseaseMESH : NeoplasmsAntineoplastic Agents PhytogenicchemistryResveratrolMolecular MedicineMESH : AnimalsCarcinogenesisCurrent Drug Targets
researchProduct

Determination of the irradiation field at the research reactor TRIGA Mainz for BNCT.

2009

For the application of the BNCT for the excorporal treatment of organs at the TRIGA Mainz, the basic characteristics of the radiation field in the thermal column as beam geometry, neutron and gamma ray energies, angular distributions, neutron flux, as well as absorbed gamma and neutron doses must be determined in a reproducible way. To determine the mixed irradiation field thermoluminescence detectors (TLD) made of CaF(2):Tm with a newly developed energy-compensation filter system and LiF:Mg,Ti materials with different (6)Li concentrations and different thicknesses as well as thin gold foils were used.

Radiation-Sensitizing AgentsMaterials scienceAstrophysics::High Energy Astrophysical PhenomenaPhysics::Medical PhysicsBoron Neutron Capture TherapyIn Vitro TechniquesThermoluminescenceTransplantation AutologousTRIGAFast NeutronsFluoridesIsotopesNeutron fluxNuclear ReactorsGermanyHumansNeutronIrradiationBoronRadiationPhantoms ImagingRadiotherapy Planning Computer-AssistedRadiochemistryLiver NeoplasmsGamma rayLiver TransplantationTransplantationEnergy TransferGamma RaysLithium CompoundsThermoluminescent DosimetryThermoluminescent dosimeterApplied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine
researchProduct

Factors affecting the amount and the mode of merocyanine 540 binding to the membrane of human erythrocytes. A comparison with the binding to leukemia…

1995

Abstract In the presence of albumin Merocyanine 540 (MC540) exhibits a very limited binding to the outer surface of the membrane of normal erythrocytes, whereas pronounced binding is observed to leukemia cells. To find out whether this difference is due to differences in the composition or structural organization of the cell membrane we analyzed effects of a number of covalent and non-covalent perturbations of the red cell membrane on the binding and fluorescence characteristics of membrane-bound MC540. It is shown that exposure of the cells to cationic chlorpromazine, neuraminidase or photodynamic treatment with AlPcS 4 as sensitizer caused a limited increase (30–50%) of MC540 binding, tog…

Radiation-Sensitizing AgentsTMA-DPHHot TemperatureIndolesBSALightChlorpromazineLipid BilayersBiophysicsPhospholipidNeuraminidaseQuantum yieldPyrimidinonesBiochemistryCell membranechemistry.chemical_compoundt-BuOOHOrganometallic CompoundsTumor Cells CulturedmedicineMerocyanine 540HumansPBSCell MembraneErythrocyte MembraneMembrane structureCell Biologymedicine.diseasePEGFluorescenceDIDSLeukemiaLeukemia cellAlPcS4CholesterolSpectrometry FluorescenceMembranemedicine.anatomical_structureBNML cellsBiochemistrychemistryLeukemia MyeloidCovalent bondBiophysicsMC540Biochimica et Biophysica Acta (BBA) - Biomembranes
researchProduct